Rachel Hardeman, a leader in health equity and anti-racism research, and Melissa Simon, an OB-GYN specializing in women's health, delve into the precarious impact of recent bans on diversity, equity, and inclusion in medical research. They discuss how these restrictions threaten essential studies, particularly in women's and reproductive health. The irony of cutting fertility care while worrying about birth rates is examined, along with concerns over potential censorship in medical research language and the urgent need to maintain diversity for equitable health outcomes.
